Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' PRETLOW TP' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 31 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Hao, XP; Pretlow, TG; Rao, JS; Pretlow, TP
      beta-catenin expression is altered in human colonic aberrant crypt foci

      CANCER RESEARCH
    2. Pretlow, TP; Bird, RP
      Correspondence re: Y. Yamada et al., frequent beta-catenin gene mutations and accumulations of the protein in the putative preneoplastic lesions lacking macroscopic aberrant crypt foci appearance, in rat colon carcinogenesis. Cancer Res., 60 : 3323-3327, 2000; and sequential analysis of morphological and biological properties of beta-catenin-accumulated crypts, provable premalignant lesions independent of aberrant crypt foci in rat colon carcinogenesis. Cancer Res., 61 : 1874-1878, 2001.

      CANCER RESEARCH
    3. Hao, XP; Pretlow, TG; Rao, JS; Pretlow, TP
      Inducible nitric oxide synthase (iNOS) is expressed similarly in multiple aberrant crypt foci and colorectal tumors from the same patients

      CANCER RESEARCH
    4. Pretlow, TG; Schwartz, S; Giaconia, JM; Wright, AL; Grimm, HA; Edgehouse, NL; Murphy, JR; Markowitz, SD; Jamison, JM; Summers, JL; Hamlin, CR; MacLennan, GT; Resnick, MI; Pretlow, TP; Connell, CF
      Prostate cancer and other xenografts from cells in peripheral blood of patients

      CANCER RESEARCH
    5. Hao, XP; Willis, JE; Pretlow, TG; Rao, JS; MacLennan, GT; Talbot, IC; Pretlow, TP
      Loss of fragile histidine triad expression in colorectal carcinomas and premalignant lesions

      CANCER RESEARCH
    6. Sramkoski, RM; Pretlow, TG; Giaconia, JM; Pretlow, TP; Schwartz, S; Sy, MS; Marengo, SR; Rhim, JS; Zhang, DS; Jacobberger, JW
      A new human prostate carcinoma cell line, 22R upsilon 1

      IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL
    7. Kochera, M; Depinet, TW; Pretlow, TP; Giaconia, JM; Edgehouse, NL; Pretlow, TG; Schwartz, S
      Molecular cytogenetic studies of a serially transplanted primary prostaticcarcinoma xenograft (CWR22) and four relapsed tumors

      PROSTATE
    8. Siu, IM; Robinson, DR; Schwartz, S; Kung, HJ; Pretlow, TG; Petersen, RB; Pretlow, TP
      The identification of monoclonality in human aberrant crypt foci

      CANCER RESEARCH
    9. PRETLOW TP; PRETLOW TG
      PUTATIVE PRENEOPLASTIC CHANGES IDENTIFIED BY ENZYME-HISTOCHEMICAL ANDIMMUNOHISTOCHEMICAL TECHNIQUES

      The Journal of histochemistry and cytochemistry
    10. DAWSON DM; LAWRENCE EG; MACLENNAN GT; AMINI SB; KUNG HJ; ROBINSON D; RESNICK MI; KURSH ED; PRETLOW TP; PRETLOW TG
      ALTERED EXPRESSION OF RET PROTOONCOGENE PRODUCT IN PROSTATIC INTRAEPITHELIAL NEOPLASIA AND PROSTATE-CANCER

      Journal of the National Cancer Institute
    11. SIU IM; PRETLOW TG; AMINI SB; PRETLOW TP
      IDENTIFICATION OF DYSPLASIA IN HUMAN COLONIC ABERRANT CRYPT FOCI

      The American journal of pathology
    12. AUGENLICHT LH; RICHARDS C; CORNER G; PRETLOW TP
      EVIDENCE FOR GENOMIC INSTABILITY IN HUMAN COLONIC ABERRANT CRYPT FOCI

      Oncogene
    13. PRETLOW TG; PRETLOW TP
      ANDROGEN-DEPENDENT PROSTATE-CANCER XENOGRAFT AND RELAPSED STRAINS

      The FASEB journal
    14. WHITELEY LO; HUDSON L; PRETLOW TP
      ABERRANT CRYPT FOCI IN THE COLONIC MUCOSA OF RATS TREATED WITH A GENOTOXIC AND NONGENOTOXIC COLON CARCINOGEN

      Toxicologic pathology
    15. KONSTANTAKOS AK; SIU IM; PRETLOW TG; STELLATO TA; PRETLOW TP
      HUMAN ABERRANT CRYPT FOCI WITH CARCINOMA IN-SITU FROM A PATIENT WITH SPORADIC COLON-CANCER

      Gastroenterology
    16. FENG Y; WAGNER RJ; FRETLAND AJ; BECKER WK; COOLEY AM; PRETLOW TP; LEE KJ; HEIN DW
      ACETYLATOR GENOTYPE (NAT2)-DEPENDENT FORMATION OF ABERRANT CRYPTS IN CONGENIC SYRIAN-HAMSTERS ADMINISTERED 3,2'-DIMETHYL-4-AMINOBIPHENYL

      Cancer research
    17. NAGABHUSHAN M; MILLER CM; PRETLOW TP; GIACONIA JM; EDGEHOUSE NL; SCHWARTZ S; KUNG HJ; WHITE RWD; GUMERLOCK PH; RESNICK MI; AMINI SB; PRETLOW TG
      CWR22 - THE FIRST HUMAN PROSTATE-CANCER XENOGRAFT WITH STRONGLY ANDROGEN-DEPENDENT RELAPSED STRAINS BOTH IN-VIVO AND IN SOFT AGAR

      Cancer research
    18. CHENG L; NAGABHUSHAN M; PRETLOW TP; AMINI SB; PRETLOW TG
      EXPRESSION OF E-CADHERIN IN PRIMARY AND METASTATIC PROSTATE-CANCER

      The American journal of pathology
    19. NAGABHUSHAN M; PRETLOW TG; GUO YJ; AMINI SB; PRETLOW TP; SY MS
      ALTERED EXPRESSION OF CD44 IN HUMAN PROSTATE-CANCER DURING PROGRESSION

      American journal of clinical pathology
    20. PRETLOW TG; YANG B; PRETLOW TP
      ORGAN-CULTURE OF BENIGN, AGING, AND HYPERPLASTIC HUMAN PROSTATE

      Microscopy research and technique
    21. PRETLOW TG; NAGABHUSHAN M; PRETLOW TP
      PROSTATIC INTRAEPITHELIAL NEOPLASIA AND OTHER CHANGES DURING PROMOTION AND PROGRESSION

      Pathology research and practice
    22. ZAIDI NH; PRETLOW TP; ORIORDAN MA; DUMENCO LL; ALLAY E; GERSON SL
      TRANSGENIC EXPRESSION OF HUMAN MGMT PROTECTS AGAINST AZOXYMETHANE-INDUCED ABERRANT CRYPT FOCI AND G-TO-A MUTATIONS IN THE K-RAS ONCOGENE OFMOUSE COLON

      Carcinogenesis
    23. PRETLOW TP
      ABERRANT CRYPT FOCI AND K-RAS MUTATIONS - EARLIEST RECOGNIZED PLAYERSOR INNOCENT BYSTANDERS IN COLON CARCINOGENESIS

      Gastroenterology
    24. PRETLOW TG; NAGABHUSHAN M; SY M; GUO YJ; PRETLOW TP
      PUTATIVE PRENEOPLASTIC FOCI IN THE HUMAN PROSTATE

      Journal of cellular biochemistry
    25. PRETLOW TP; CHEYER C; ORIORDAN MA
      ABERRANT CRYPT FOCI AND COLON TUMORS IN F344 RATS HAVE SIMILAR INCREASES IN PROLIFERATIVE ACTIVITY

      International journal of cancer
    26. PRETLOW TP; ROUKHADZE EV; ORIORDAN MA; CHAN JC; AMINI SB; STELLATO TA
      CARCINOEMBRYONIC ANTIGEN IN HUMAN COLONIC ABERRANT CRYPT FOCI

      Gastroenterology
    27. WAINSTEIN MA; HE F; ROBINSON D; KUNG HJ; SCHWARTZ S; GIACONIA JM; EDGEHOUSE NL; PRETLOW TP; BODNER DR; KURSH ED; RESNICK MI; SEFTEL A; PRETLOW TG
      CWR22 - ANDROGEN-DEPENDENT XENOGRAFT MODEL DERIVED FROM A PRIMARY HUMAN PROSTATIC-CARCINOMA

      Cancer research
    28. MONGER LE; NAGABHUSHAN M; PRETLOW TG; PRETLOW TP
      A NOVEL-APPROACH TO THE CHARACTERIZATION OF WHOLE PROSTATE PATHOLOGY IN GLYCOL METHACRYLATE

      The American journal of pathology
    29. PRETLOW TG; OGRINC GS; AMINI SB; DELMORO CM; MOLKENTIN KF; WILLSON JKV; PRETLOW TP
      A BETTER DEFINED MEDIUM FOR HUMAN PROSTATE-CANCER CELLS

      In vitro cellular & developmental biology. Animal
    30. PRETLOW TP; ORIORDAN MA; SPANCAKE KM; PRETLOW TG
      2 TYPES OF PUTATIVE PRENEOPLASTIC LESIONS IDENTIFIED BY HEXOSAMINIDASE ACTIVITY IN WHOLE-MOUNTS OF COLONS FROM F344 RATS TREATED WITH CARCINOGEN

      The American journal of pathology
    31. PRETLOW TP; BRASITUS TA; FULTON NC; CHEYER C; KAPLAN EL
      K-RAS MUTATIONS IN PUTATIVE PRENEOPLASTIC LESIONS IN HUMAN COLON

      Journal of the National Cancer Institute


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 11/08/20 alle ore 22:02:03